-
1
-
-
72049129149
-
A difficult balance-pain management, drug safety, and the FDA
-
Woodcock J. A difficult balance-pain management, drug safety, and the FDA. N Engl J Med. 2009;361(22):2105-2107.
-
(2009)
N Engl J Med
, vol.361
, Issue.22
, pp. 2105-2107
-
-
Woodcock, J.1
-
3
-
-
0030777012
-
The capsaicin receptor: A heat-activated ion channel in the pain pathway
-
DOI 10.1038/39807
-
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389(6653):816-824. (Pubitemid 27462969)
-
(1997)
Nature
, vol.389
, Issue.6653
, pp. 816-824
-
-
Caterina, M.J.1
Schumacher, M.A.2
Tominaga, M.3
Rosen, T.A.4
Levine, J.D.5
Julius, D.6
-
4
-
-
0032169804
-
The cloned capsaicin receptor integrates multiple pain-producing stimuli
-
DOI 10.1016/S0896-6273(00)80564-4
-
Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21(3):531-543. (Pubitemid 28475505)
-
(1998)
Neuron
, vol.21
, Issue.3
, pp. 531-543
-
-
Tominaga, M.1
Caterina, M.J.2
Malmberg, A.B.3
Rosen, T.A.4
Gilbert, H.5
Skinner, K.6
Raumann, B.E.7
Basbaum, A.I.8
Julius, D.9
-
5
-
-
0033984992
-
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
-
Smart D, Gunthorpe MJ, Jerman JC, et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 2000;129(2):227-230. (Pubitemid 30072640)
-
(2000)
British Journal of Pharmacology
, vol.129
, Issue.2
, pp. 227-230
-
-
Smart, D.1
Gunthorpe, M.J.2
Jerman, J.C.3
Nasir, S.4
Gray, J.5
Muir, A.I.6
Chambers, J.K.7
Randall, A.D.8
Davis, J.B.9
-
6
-
-
0037062411
-
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
-
DOI 10.1073/pnas.122196999
-
Huang SM, Bisogno T, Trevisani M, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A. 2002; 99(12):8400-8405. (Pubitemid 34651064)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.12
, pp. 8400-8405
-
-
Huang, S.M.1
Bisogno, T.2
Trevisani, M.3
Al-Hayani, A.4
De Petrocellis, L.5
Fezza, F.6
Tognetto, M.7
Petros, T.J.8
Krey, J.F.9
Chu, C.J.10
Miller, J.D.11
Davies, S.N.12
Geppetti, P.13
Walker, J.M.14
Di, M.V.15
-
7
-
-
0035927651
-
2-mediated inhibition
-
DOI 10.1038/35082088
-
Chuang H-H, Prescott ED, Kong H, et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5) P2-mediated inhibition. Nature. 2001;411(6840):957-962. (Pubitemid 32601493)
-
(2001)
Nature
, vol.411
, Issue.6840
, pp. 957-962
-
-
Chuang, H.-H.1
Prescott, E.D.2
Kong, H.3
Shields, S.4
Jordt, S.-E.5
Basbaum, A.I.6
Chao, M.V.7
Julius, D.8
-
8
-
-
0034926291
-
The vanilloid receptor: A molecular gateway to the pain pathway
-
DOI 10.1146/annurev.neuro.24.1.487
-
Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci. 2001;24:487-517. (Pubitemid 32695237)
-
(2001)
Annual Review of Neuroscience
, vol.24
, pp. 487-517
-
-
Caterina, M.J.1
Julius, D.2
-
9
-
-
0141738818
-
Vanilloid receptors take a TRP beyond the sensory afferent
-
DOI 10.1016/S0304-3959(03)00259-8
-
Caterina MJ. Vanilloid receptors take a TRP beyond the sensory afferent. Pain. 2003;105(1-2):5-9. (Pubitemid 37162468)
-
(2003)
Pain
, vol.105
, Issue.1-2
, pp. 5-9
-
-
Caterina, M.J.1
-
10
-
-
0036303675
-
Vanilloid (capsaicin) receptors in health and disease
-
DOI 10.1309/7AYY-VVH1-GQT5-J4R2
-
Szallasi A. Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol. 2002;118(1):110-121. (Pubitemid 34734260)
-
(2002)
American Journal of Clinical Pathology
, vol.118
, Issue.1
, pp. 110-121
-
-
Szallasi, A.1
-
11
-
-
34248138496
-
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
-
DOI 10.1038/nrd2280, PII NRD2280
-
Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-oncept. Nat Rev Drug Discov. 2007;6(5):357-372. (Pubitemid 46705200)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.5
, pp. 357-372
-
-
Szallasi, A.1
Cortright, D.N.2
Blum, C.A.3
Eid, S.R.4
-
12
-
-
12744279751
-
Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons
-
Wilson-Gerwing TD, Dmyterko MV, Zochodne DW, Johnston JM, Verge VM. Neurotrophin-3 suppresses thermal hyperalgesia associated with neuropathic pain and attenuates transient receptor potential vanilloid receptor-1 expression in adult sensory neurons. J Neurosci. 2005;25(3):758-767.
-
(2005)
J Neurosci
, vol.25
, Issue.3
, pp. 758-767
-
-
Wilson-Gerwing, T.D.1
Dmyterko, M.V.2
Zochodne, D.W.3
Johnston, J.M.4
Verge, V.M.5
-
13
-
-
23944442240
-
Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis
-
DOI 10.1016/j.neulet.2005.06.044, PII S0304394005007457
-
Fernihough J, Gentry C, Bevan S, Winter J. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett. 2005;388(2):75-80. (Pubitemid 41206735)
-
(2005)
Neuroscience Letters
, vol.388
, Issue.2
, pp. 75-80
-
-
Fernihough, J.1
Gentry, C.2
Bevan, S.3
Winter, J.4
-
14
-
-
34548439903
-
Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons
-
DOI 10.1016/j.neuroscience.2007.05.049, PII S0306452207006641
-
Niiyama Y, Kawamata T, Yamamoto J, Omote K, Namiki A. Bone cancer increases transient receptor potential vanilloid sub-amily 1 expression within distinct subpopulations of dorsal root ganglion neurons. Neuroscience. 2007;148(2):560-572. (Pubitemid 47362498)
-
(2007)
Neuroscience
, vol.148
, Issue.2
, pp. 560-572
-
-
Niiyama, Y.1
Kawamata, T.2
Yamamoto, J.3
Omote, K.4
Namiki, A.5
-
15
-
-
0035962308
-
Vanilloid receptor 1 immunoreactivity in inflamed human bowel
-
DOI 10.1016/S0140-6736(00)04503-7
-
Yiangou Y, Facer P, Dyer NHC, et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet. 2001;357(9265): 1338-1339. (Pubitemid 32441536)
-
(2001)
Lancet
, vol.357
, Issue.9265
, pp. 1338-1339
-
-
Yiangou, Y.1
Facer, P.2
Dyer, N.H.C.3
Chan, C.L.H.4
Knowles, C.5
Williams, N.S.6
Anand, P.7
-
16
-
-
1542374082
-
Increased vanilloid receptor VR1 innervation in vulvodynia
-
DOI 10.1016/S1090-3801(03)00085-5
-
Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain. 2004;8(2):129-133. (Pubitemid 38325882)
-
(2004)
European Journal of Pain
, vol.8
, Issue.2
, pp. 129-133
-
-
Tympanidis, P.1
Casula, M.A.2
Yiangou, Y.3
Terenghi, G.4
Dowd, P.5
Anand, P.6
-
17
-
-
26944452843
-
Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain
-
Morgan CR, Rodd HD, Clayton N, Davis JB, Boissonade FM. Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain. J Orofac Pain. 2005;19(3):248-260. (Pubitemid 41482014)
-
(2005)
Journal of Orofacial Pain
, vol.19
, Issue.3
, pp. 248-260
-
-
Morgan, C.R.1
Rodd, H.D.2
Clayton, N.3
Davis, J.B.4
Boissonade, F.M.5
-
18
-
-
0034646740
-
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
-
DOI 10.1126/science.288.5464.306
-
Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000;288(5464):306- 313. (Pubitemid 30226186)
-
(2000)
Science
, vol.288
, Issue.5464
, pp. 306-313
-
-
Caterina, M.J.1
Leffler, A.2
Malmberg, A.B.3
Martin, W.J.4
Trafton, J.5
Petersen-Zeitz, K.R.6
Koltzenburg, M.7
Basbaum, A.I.8
Julius, D.9
-
19
-
-
0034636441
-
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
-
DOI 10.1038/35012076
-
Davis JB, Gray J, Gunthorpe MJ, et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 2000; 405(6783):183-187. (Pubitemid 30313536)
-
(2000)
Nature
, vol.405
, Issue.6783
, pp. 183-187
-
-
Davis, J.B.1
Gray, J.2
Gunthorpe, M.J.3
Hatcher, J.P.4
Davey, P.T.5
Overend, P.6
Harries, M.H.7
Latcham, J.8
Clapham, C.9
Atkinson, K.10
Hughes, S.A.11
Rance, K.12
Grau, E.13
Harper, A.J.14
Pugh, P.L.15
Rogers, D.C.16
Bingham, S.17
Randall, A.18
Sheardown, S.A.19
-
20
-
-
33750323945
-
Attenuation of experimental arthritis in TRPV1R knockout mice
-
DOI 10.1016/j.yexmp.2006.04.007, PII S0014480006000517
-
Barton NJ, McQueen DS, Thomson D, et al. Attenuation of experimental arthritis in TRPV1R knockout mice. Exp Mol Pathol. 2006;81(2):166-170. (Pubitemid 44715790)
-
(2006)
Experimental and Molecular Pathology
, vol.81
, Issue.2
, pp. 166-170
-
-
Barton, N.J.1
McQueen, D.S.2
Thomson, D.3
Gauldie, S.D.4
Wilson, A.W.5
Salter, D.M.6
Chessell, I.P.7
-
21
-
-
0037215646
-
The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain
-
DOI 10.1124/jpet.102.042010
-
Walker KM, Urban L, Medhurst SJ, et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Therapeut. 2003; 304(1):56-62. (Pubitemid 36008912)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.304
, Issue.1
, pp. 56-62
-
-
Walker, K.M.1
Urban, L.2
Medhurst, S.J.3
Patel, S.4
Panesar, M.5
Fox, A.J.6
McIntyre, P.7
-
22
-
-
33750358054
-
TRPV1: A therapeutic target for novel analgesic drugs?
-
DOI 10.1016/j.molmed.2006.09.001, PII S1471491406001973
-
Szallasi A, Cruz F, Geppetti P. TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol Med. 2006;12(11):545-554. (Pubitemid 44633805)
-
(2006)
Trends in Molecular Medicine
, vol.12
, Issue.11
, pp. 545-554
-
-
Szallasi, A.1
Cruz, F.2
Geppetti, P.3
-
23
-
-
60049089359
-
Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia
-
Honore P, Chandran P, Hernandez G, et al. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain. 2009;142(1-2):27-35.
-
(2009)
Pain
, vol.142
, Issue.1-2
, pp. 27-35
-
-
Honore, P.1
Chandran, P.2
Hernandez, G.3
-
24
-
-
33748680717
-
TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists
-
DOI 10.1523/JNEUROSCI.1246-06.2006
-
Cui M, Honore P, Zhong C, et al. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci. 2006;26(37):9385-9393. (Pubitemid 44396851)
-
(2006)
Journal of Neuroscience
, vol.26
, Issue.37
, pp. 9385-9393
-
-
Cui, M.1
Honore, P.2
Zhong, C.3
Gauvin, D.4
Mikusa, J.5
Hernandez, G.6
Chandran, P.7
Gomtsyan, A.8
Brown, B.9
Bayburt, E.K.10
Marsh, K.11
Bianchi, B.12
McDonald, H.13
Niforatos, W.14
Neelands, T.R.15
Moreland, R.B.16
Decker, M.W.17
Lee, C.-H.18
Sullivan, J.P.19
Faltynek, C.R.20
more..
-
25
-
-
20144388484
-
Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain
-
DOI 10.1523/JNEUROSCI.3815-04.2005
-
Ghilardi JR, Rohrich H, Lindsay TH, et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci. 2005;25(12):3126-3131. (Pubitemid 40463547)
-
(2005)
Journal of Neuroscience
, vol.25
, Issue.12
, pp. 3126-3131
-
-
Ghilardi, J.R.1
Rohrich, H.2
Lindsay, T.H.3
Sevcik, M.A.4
Schwei, M.J.5
Kubota, K.6
Halvorson, K.G.7
Poblete, J.8
Chaplan, S.R.9
Dubin, A.E.10
Carruthers, N.I.11
Swanson, D.12
Kuskowski, M.13
Flores, C.M.14
Julius, D.15
Mantyh, P.W.16
-
26
-
-
53849138741
-
(R)-(5-tertbutyl- 2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT- 102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo
-
Surowy CS, Neelands TR, Bianchi BR, et al. (R)-(5-tertbutyl- 2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT- 102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo. J Pharmacol Exp Ther. 2008;326(3): 879-888.
-
(2008)
J Pharmacol Exp Ther
, vol.326
, Issue.3
, pp. 879-888
-
-
Surowy, C.S.1
Neelands, T.R.2
Bianchi, B.R.3
-
27
-
-
39149117718
-
Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H- indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management
-
DOI 10.1021/jm701007g
-
Gomtsyan A, Bayburt EK, Schmidt RG, et al. Identification of (R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl) urea (ABT-102) as a potent TRPV1 antagonist for pain management. J Med Chem. 2008;51(3):392-395. (Pubitemid 351252266)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.3
, pp. 392-395
-
-
Gomtsyan, A.1
Bayburt, E.K.2
Schmidt, R.G.3
Surowy, C.S.4
Honore, P.5
Marsh, K.C.6
Hannick, S.M.7
McDonald, H.A.8
Wetter, J.M.9
Sullivan, J.P.10
Jarvis, M.F.11
Faltynek, C.R.12
Lee, C.-H.13
-
28
-
-
34047118624
-
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation
-
DOI 10.1523/JNEUROSCI.4833-06.2007
-
Gavva NR, Bannon AW, Surapaneni S, et al. The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci. 2007;27(13):3366-3374. (Pubitemid 46515121)
-
(2007)
Journal of Neuroscience
, vol.27
, Issue.13
, pp. 3366-3374
-
-
Gavva, N.R.1
Bannon, A.W.2
Surapaneni, S.3
Hovland Jr., D.N.4
Lehto, S.G.5
Gore, A.6
Juan, T.7
Deng, H.8
Han, B.9
Klionsky, L.10
Kuang, R.11
Le, A.12
Tamir, R.13
Wang, J.14
Youngblood, B.15
Zhu, D.16
Norman, M.H.17
Magal, E.18
Treanor, J.J.S.19
Louis, J.-C.20
more..
-
29
-
-
34548825160
-
Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
-
DOI 10.1124/jpet.107.125674
-
Gavva NR, Bannon AW, Hovland DN Jr, et al. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade. J Pharmacol Exp Ther. 2007;323(1):128-137. (Pubitemid 47443270)
-
(2007)
Journal of Pharmacology and Experimental Therapeutics
, vol.323
, Issue.1
, pp. 128-137
-
-
Gavva, N.R.1
Bannon, A.W.2
Hovland Jr., D.N.3
Lehto, S.G.4
Klionsky, L.5
Surapaneni, S.6
Immke, D.C.7
Henley, C.8
Arik, L.9
Bak, A.10
Davis, J.11
Ernst, N.12
Hever, G.13
Kuang, R.14
Shi, L.15
Tamir, R.16
Wang, J.17
Wang, W.18
Zajic, G.19
Zhu, D.20
Norman, M.H.21
Louis, J.-C.22
Magal, E.23
Treanor, J.J.S.24
more..
-
30
-
-
68349110925
-
Highly sensitive LC-MS-MS analysis of a pharmaceutical compound in human plasma using monolithic phase-based on-line extraction
-
Xu RN, Vaca P, Rieser MJ, El-Shourbagy TA. Highly sensitive LC-MS-MS analysis of a pharmaceutical compound in human plasma using monolithic phase-based on-line extraction. J Chromatogr Sci. 2009;47(6):473-477.
-
(2009)
J Chromatogr Sci
, vol.47
, Issue.6
, pp. 473-477
-
-
Xu, R.N.1
Vaca, P.2
Rieser, M.J.3
El-Shourbagy, T.A.4
-
31
-
-
34748854885
-
Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies
-
DOI 10.1007/s10928-007-9066-0
-
Savic RM, Jonker DM, Kerbusch T, Karlsson MO. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2007;34(5):711-726. (Pubitemid 47477040)
-
(2007)
Journal of Pharmacokinetics and Pharmacodynamics
, vol.34
, Issue.5
, pp. 711-726
-
-
Savic, R.M.1
Jonker, D.M.2
Kerbusch, T.3
Karlsson, M.O.4
-
34
-
-
79954584227
-
Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial
-
Mar 3. [Epub ahead of print]
-
Rowbotham M, Nothaft W, Duan WR, et al. Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. Pain. 2011 Mar 3. [Epub ahead of print]
-
(2011)
Pain
-
-
Rowbotham, M.1
Nothaft, W.2
Duan, W.R.3
-
36
-
-
35848952270
-
Conditional weighted residuals (CWRES): A model diagnostic for the FOCE method
-
DOI 10.1007/s11095-007-9361-x
-
Hooker AC, Staatz CE, Karlsson MO. Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method. Pharm Res. 2007;24(12):2187- 2197. (Pubitemid 350060706)
-
(2007)
Pharmaceutical Research
, vol.24
, Issue.12
, pp. 2187-2197
-
-
Hooker, A.C.1
Staatz, C.E.2
Karlsson, M.O.3
|